Yann De Rycke

Targeting population entering phase III trials: A new stratified adaptive phase II design

Pascale Tubert-Bitter, Caroline Tournoux-Facon, Yann De Rycke, 2011, Statistics in medicine.

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up

Philippe Broët, Yann De Rycke, Lisa Belin, 2017, Contemporary clinical trials communications.

ASSESSMENT OF ORGAN ABSORBED DOSES AND ESTIMATION OF EFFECTIVE DOSES FROM PEDIATRIC ANTHROPOMORPHIC PHANTOM MEASUREMENTS FOR MULTI-DETECTOR ROW CT WITH AND WITHOUT AUTOMATIC EXPOSURE CONTROL

Geneviève Gaboriaud, Yann De Rycke, H. Brisse, 2009, Health physics.

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review

Yann De Rycke, Sylvie Guillo, F. Tubach, 2017, BMC Medical Research Methodology.

Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review.

Bernard Asselain, Yann De Rycke, Youlia M Kirova, 2007, International journal of radiation oncology, biology, physics.

A prognostic DNA signature for T1T2 node‐negative breast cancer patients

Anne Vincent-Salomon, Bernard Asselain, Olivier Delattre, 2010, Genes, chromosomes & cancer.

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma

Roman Rouzier, Anne Vincent-Salomon, Fabien Reyal, 2011, PloS one.

Methods of joint evaluation of efficacy and toxicity in phase II clinical trials.

Bernard Asselain, Yann De Rycke, B. Asselain, 2007, Contemporary clinical trials.

Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.

Bernard Dubray, Vincent Servois, Philippe Giraud, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Arthur André, Jean-Yves Chapelon, Laurent Capelle, 2019, Clinical Cancer Research.

High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.

Emmanuel Barillot, Nicolas Servant, Philippe Hupé, 2008, Journal of the National Cancer Institute.